Malignant Neoplasms
The liver is the most common site of metastasis from other cancers. Liver metastases arc found at autopsy in 30% to 50%> of patients with cancer.
Primary malignancy of the liver is rare in the USA and Western Europe but common in Africa and Asia. About 90% of primary adult hepatic cancers originate in the hepatocyle and are called hepatocellular carcinoma or hepatoma; 5% to 10% originate in the bile ducts as chol-angiocarcinoma or are a mixed type, cholangiohepatoma. Other primary liver cancers are exceedingly rare and include cystadenocarcinoma, angiosarcoma, and hepatoblastoma. Hepatic malignancies are more common in men than in women and occur between ages 50 and 70.
Hepatocellular carcinoma may be nodular, massive, or diffuse. The nodular type, which is the most common, consists of multiple discrete nodules. The massive type, which essentially accounts for the rest, develops as a large, often necrotic, hemorrhagic mass. The diffuse type is most often associated with cirrhosis and consislsof minule lesions scattered Ihroughout the liver. Predisposing factors include hepatitis B. hepatitis C, alcohol or tobacco use, cirrhosis, and aflatoxin exposure.
Symptoms and Signs
About 70% of patients present with right upper quadrant or epigastric pain and weight loss. With progressive liver dysfunction, menial status may deteriorate. Pulmonary symptoms and pathologic fractures may result from metastases. A rare lumor rupture with intra-abdominal hemorrhage and symptoms of an acute abdomen is life threatening.
Physical examination may reveal hepatomegaly, a right upper quadrant mass, or ascites. Splenomegaly is less common. Lymphadcnop-athy, especially in the right supraclavicular region, can occur. Gynecomastia is rare.
Paraneoplastic syndromes associaled with hepatocellular carcinoma include erythrocytosis. hypercalcemia, hypoglycemia, hyperlipemia, porphyria cutanea tarda, and dysfibrinoginemia.
Diagnosis
Liver function test results arc usually abnormal. Elevated serum alkaline phosphatase levels are common, but elevated serum aminotransferases and bilirubin levels are less so. Hepatitis B surface antigen and hepatitis C virus markers may be positive. Elevaled levels of α-fetoprotein are noted in 90% of patients with hepatocellular carcinoma.
20%. Metastasis is found in 75% of cases a! the lime of diagnosis. Workers in rubber and automotive plants have a particularly high risk of gallbladder cancer.
Gallstones are associated with the development of gallbladder carcinoma, and preventing such carcinoma may justify early cholecystectomy in patients with cholelithiasis.
Symptoms, Signs, and Diagnosis
Symptoms include intermittent pain and dyspepsia similar to that of chronic cholecystitis. In the late stages, weight loss and jaundice develop. Often a firm, tender mass is palpable in the right upper quadrant. Abdominal ultrasonography and CT scan provide visualization of the tumor. Endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography is useful for a complete evaluation of the biliary tree.
Treatment
Radical cholecystectomy is the treatment of choice for localized disease. Radiation therapy and chemotherapy are ineffective. The prognosis is dismal; the 5-yr survival rate is only 5%. Biliary stenting by endoscopic refrograde cholangiopancreatography or percutaneous transhepatic cholangiography may provide limited palliation of an obstruction.
posted in The Aging Liver | 0 Comments